Association of NAFLD and Insulin Resistance with Non Metastatic Bladder Cancer Patients: A Cross-Sectional Retrospective Study
Giovanni Tarantino(Federico II University Hospital), Ciro Imbimbo(University of Naples Federico II), Raffaele Martino(University of Naples Federico II), Massimiliano Creta(University of Naples Federico II), Salvatore Pesce(University of Naples Federico II), Felice Crocetto(University of Naples Federico II), Savio Domenico Pandolfo(University of Salerno), Concetta Di Vito(University of Naples Federico II), Domênico Capone(Universidade Federal do Rio de Janeiro), Luigi Napolitano(University of Naples Federico II)
Cited by 131
Related Papers
Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets
|International Journal of Molecular Sciences|2022|190
Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice
|Biomedicines|2023|161
Cellular and Molecular Players in the Tumor Microenvironment of Renal Cell Carcinoma
|Journal of Clinical Medicine|2023|129
Combination of Bevacizumab and Docetaxel in Docetaxel-Pretreated Hormone-Refractory Prostate Cancer: A Phase 2 Study
|European Urology|2008|128
Radiogenomics in Renal Cancer Management—Current Evidence and Future Prospects
|International Journal of Molecular Sciences|2023|124